Goldman Sachs upgraded its stance on Brazilian equities Wednesday, identifying selective value in retail after the sector plunged 33% on average since the October 30 runoff, sharply underperforming the Ibovespa's 14% decline. The bank maintains buy ratings on Mercado Livre (MELI34), RD Saúde (RADL3), Assaí (ASAI3), and Smart Fit (SMFT3), citing a median forward price-to-earnings of 7.6x versus a 10.9x historical norm when real rates trade at 7–8%.
The post-election selloff reflects heightened political risk premium and aggressive foreign capital rotation, with overseas investors withdrawing R$2.8 billion from B3 in a single session and October inflows slowing to R$13.3 billion. This dynamic mirrors broader Ibovespa futures pressure ahead of the Federal Reserve decision, as global rate sensitivity amplifies local fiscal concerns. Historically, such dislocations between quality compounders and broad indices create asymmetric entry points when real yields stabilize.
Market Impact & Transmission Channels
The valuation compression from 10.9x to 7.6x forward earnings transmits through three channels: first, higher equity risk premiums demanded by foreign allocators reprice duration-heavy growth names like Mercado Livre, whose $2,230 Nasdaq target implies 45% annual EPS growth through 2029; second, defensive domestic operators such as RD Saúde (R$26 target) benefit from inelastic healthcare demand and market-share gains, insulating margins from consumption cycles; third, Assaí (R$13.50) and Smart Fit (R$38) capture structural formalization and wellness trends, respectively, offering operating leverage once consumer confidence recovers.
The dispersion between sector beta and idiosyncratic quality is the widest since 2016; capital will rotate from macro hedges to micro compounders once the fiscal anchor clarifies.
Currency volatility remains the swing factor. A stronger real would compress imported inflation, allowing the Central Bank to accelerate easing — directly expanding multiples for rate-sensitive retail. Conversely, fiscal slippage could sustain the 33% discount to history, trapping value investors in a low-growth, high-rate equilibrium.
Key Takeaways for Investors
- Monitor: Foreign flow trajectory at B3; sustained outflows below R$10 billion monthly would signal structural re-rating risk.
- Expect: Volatility to persist until the 2024 budget framework is legislated, likely keeping retail beta elevated through Q1 2024.
- Assess: Portfolio exposure to earnings revision breadth; Goldman's four picks show positive estimate momentum versus negative sector breadth.
- Evaluate: Barbell allocation pairing Mercado Livre's dollar-denominated growth with RD Saúde's real-denominated defensiveness to hedge fiscal uncertainty.
Frequently Asked Questions
Why did Brazilian retail stocks fall 33% after the election?
The selloff reflects foreign investor concerns over fiscal expansion under the Lula administration, driving a 33% average decline in Goldman-covered retail names versus a 14% Ibovespa drop. Elevated real rates near 7–8% compounded the de-rating, compressing forward P/E to 7.6x from a 10.9x historical median.
Which Brazilian retail stocks does Goldman Sachs recommend now?
Goldman Sachs maintains buy ratings on four names: Mercado Livre (MELI34) with a $2,230 Nasdaq target, RD Saúde (RADL3) at R$26, Assaí (ASAI3) at R$13.50, and Smart Fit (SMFT3) at R$38. The selection prioritizes structural growth, pricing power, and balance-sheet resilience in a high-rate environment.